DICER1 Syndrome: Characterization of the Ocular Phenotype in a Family-Based Cohort Study.


Journal

Ophthalmology
ISSN: 1549-4713
Titre abrégé: Ophthalmology
Pays: United States
ID NLM: 7802443

Informations de publication

Date de publication:
02 2019
Historique:
received: 22 03 2018
revised: 22 09 2018
accepted: 25 09 2018
pubmed: 20 10 2018
medline: 30 11 2019
entrez: 20 10 2018
Statut: ppublish

Résumé

To characterize the ocular phenotype of DICER1 syndrome. Prospective, single-center, case-control study. One hundred three patients with an identified germline pathogenic DICER1 variant (DICER1 carriers) and 69 family control participants underwent clinical and ophthalmic examination at the National Institutes of Health between 2011 and 2016. All participants were evaluated with a comprehensive ophthalmic examination, including best-corrected visual acuity, slit-lamp biomicroscopy, and a dilated fundus examination. A subset of patients returned for a more detailed evaluation including spectral-domain OCT, color fundus photography, fundus autofluorescence imaging, visual field testing, full-field electroretinography, and genetic testing for inherited retinal degenerative diseases. Visual acuity and examination findings. Most DICER1 carriers (97%) maintained a visual acuity of 20/40 or better in both eyes. Twenty-three DICER1 carriers (22%) showed ocular abnormalities compared with 4 family controls (6%; P = 0.005). These abnormalities included retinal pigment abnormalities (n = 6 [5.8%]), increased cup-to-disc ratio (n = 5 [4.9%]), optic nerve abnormalities (n = 2 [1.9%]), epiretinal membrane (n = 2 [1.9%]), and drusen (n = 2 [1.9%]). Overall, we observed a significant difference (P = 0.03) in the rate of retinal abnormalities in DICER1 carriers (n = 11 [11%]) versus controls (n = 1 [1.5%]). One patient demonstrated an unexpected diagnosis of retinitis pigmentosa with a novel variant of unknown significance in PRPF31, and 1 showed optic nerve elevation in the setting of increased intracranial pressure (ICP) of unclear cause. Three patients (3%) demonstrated DICER1-related ciliary body medulloepithelioma (CBME), 2 of which were identified during routine examination, a higher rate than that reported previously. Ophthalmologists should be aware of the ophthalmic manifestations of DICER1 syndrome, and individuals and families should be counseled on the potential signs and symptoms. We recommend that children with a germline pathogenic variant in DICER1, especially those younger than 10 years, undergo annual dilated ophthalmic examination, looking for evidence of CBME, signs of increased ICP, and perhaps changes in the retinal pigment epithelium.

Identifiants

pubmed: 30339877
pii: S0161-6420(18)30808-X
doi: 10.1016/j.ophtha.2018.09.038
pmc: PMC6348055
mid: NIHMS1511551
pii:
doi:

Substances chimiques

DNA, Neoplasm 0
DICER1 protein, human EC 3.1.26.3
Ribonuclease III EC 3.1.26.3
DEAD-box RNA Helicases EC 3.6.4.13

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, N.I.H., Intramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

296-304

Subventions

Organisme : NCI NIH HHS
ID : R01 CA143167
Pays : United States
Organisme : Intramural NIH HHS
ID : Z99 CA999999
Pays : United States
Organisme : Intramural NIH HHS
ID : Z99 EY999999
Pays : United States

Informations de copyright

Published by Elsevier Inc.

Références

Doc Ophthalmol. 2009 Feb;118(1):69-77
pubmed: 19030905
Clin Cancer Res. 2017 Jun 15;23(12):e76-e82
pubmed: 28620008
Science. 2009 Aug 21;325(5943):965
pubmed: 19556464
Doc Ophthalmol. 2015 Feb;130(1):1-12
pubmed: 25502644
Nature. 2016 Aug 17;536(7616):285-91
pubmed: 27535533
J Clin Endocrinol Metab. 2017 May 1;102(5):1614-1622
pubmed: 28323992
FASEB J. 2014 Aug;28(8):3780-91
pubmed: 24812086
Acta Neuropathol. 2014 Jul;128(1):111-22
pubmed: 24839956
Nature. 2011 Mar 17;471(7338):325-30
pubmed: 21297615
Nat Rev Cancer. 2014 Oct;14(10):662-72
pubmed: 25176334
Pediatr Dev Pathol. 2015 Nov-Dec;18(6):504-11
pubmed: 26698637
FASEB J. 2016 Jan;30(1):23-33
pubmed: 26399786
J Ophthalmol. 2015;2015:309510
pubmed: 26124959
Nucleic Acids Res. 2016 Jan 4;44(D1):D862-8
pubmed: 26582918
Retina. 2015 May;35(5):957-65
pubmed: 25545484
Development. 2015 Jul 15;142(14):2487-98
pubmed: 26062936
Ophthalmology. 2013 Dec;120(12):2552-2559
pubmed: 23796765
Br J Ophthalmol. 2011 Jul;95(7):1001-5
pubmed: 21156700
Clin Cancer Res. 2018 May 15;24(10):2251-2261
pubmed: 29343557
Clin Genet. 2016 Aug;90(2):118-26
pubmed: 26853529
Cancer. 2015 Jan 15;121(2):276-85
pubmed: 25209242
Hum Pathol. 2015 May;46(5):783-7
pubmed: 25791583
J Med Genet. 2012 Jul;49(7):417-9
pubmed: 22717647
Genome Res. 2001 May;11(5):863-74
pubmed: 11337480
Genet Med. 2017 Feb;19(2):244-248
pubmed: 27441995
Nature. 2015 Oct 1;526(7571):68-74
pubmed: 26432245
Nat Methods. 2010 Apr;7(4):248-9
pubmed: 20354512
Surv Ophthalmol. 2002 Nov-Dec;47(6):515-32
pubmed: 12504737

Auteurs

Laryssa A Huryn (LA)

National Eye Institute, National Institutes of Health, Bethesda, Maryland. Electronic address: laryssa.huryn@nih.gov.

Amy Turriff (A)

National Eye Institute, National Institutes of Health, Bethesda, Maryland.

Laura A Harney (LA)

Health Studies, Westat, Inc., Rockville, Maryland.

Ann Garrity Carr (AG)

Health Studies, Westat, Inc., Rockville, Maryland.

Patricia Chevez-Barrios (P)

Departments of Pathology and Genomic Medicine and of Ophthalmology, Houston Methodist Hospital, Houston, Texas; Departments of Pathology and Laboratory Medicine and Ophthalmology, Weill Cornell Medical College, New York, New York; Department of Ophthalmology, Baylor College of Medicine, Houston, Texas; Section of Ophthalmology, Department of Head and Neck Surgery, The University of Texas MD, Anderson Cancer Center, Houston, Texas.

Dan S Gombos (DS)

Department of Ophthalmology, Baylor College of Medicine, Houston, Texas; Section of Ophthalmology, Department of Head and Neck Surgery, The University of Texas MD, Anderson Cancer Center, Houston, Texas; Department of Ophthalmology, Texas Children's Hospital, Houston, Texas; The Methodist Research Institute, Houston, Texas.

Radha Ram (R)

Texan Eye, Austin, Texas.

Robert B Hufnagel (RB)

National Eye Institute, National Institutes of Health, Bethesda, Maryland.

D Ashley Hill (DA)

Division of Pathology and Center for Genetic Medicine Research, Children's National Health System, Washington, D.C; Department of Integrative Systems Biology, George Washington University School of Medicine and Health Sciences, Washington, D.C.

Wadih M Zein (WM)

National Eye Institute, National Institutes of Health, Bethesda, Maryland.

Kris Ann P Schultz (KAP)

Cancer and Blood Disorders, Children's Minnesota, Minneapolis, Minnesota; International Pleuropulmonary Blastoma Registry, Minneapolis, Minnesota; International Ovarian and Testicular Stromal Tumor Registry, Minneapolis, Minnesota.

Rachel Bishop (R)

National Eye Institute, National Institutes of Health, Bethesda, Maryland.

Douglas R Stewart (DR)

Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH